在精神分裂症患者中,人口药理动力学建模用于预测Zopiclone对Clozapine的DDI
Huan-Huan Han1, Yue Zhang2, Jie Wang2
1Department of Pharmacy, The Affiliated Lianyungang Hospital of Xuzhou Medical University, Lianyungang, Jiangsu, China.
Frontiers in psychiatry
|October 8, 2025
概括
在精神分裂症患者中确定了克洛扎宾与佐皮克隆的药物相互作用. 人口药理动力学建模建议在与佐皮克隆联合使用时降低克洛沙的剂量,以进行个性化治疗.
科学领域:
- 药理学 药理学是指药理学的学科.
- 精神病学是一个精神病学.
- 临床药房 临床药房
背景情况:
- 克洛扎平是治疗精神分裂症的关键药物.
- 在接受组合治疗的精神分裂症患者中,克洛扎宾的潜在药物相互作用 (DDI) 尚不清楚.
研究的目的:
- 通过人口药理动力学 (PPK) 建模来预测克洛扎宾DDI.
- 为精神分裂症患者制定个性化的克洛扎宾治疗建议.
主要方法:
- 收集了81名精神分裂症患者的生理,生化和药物数据.
- 应用PPK建模来识别潜在的DDI并建议剂量调整.
主要成果:
- 体重和同时服用佐皮克隆显著影响了克洛扎清除.
- 鉴定了clozapine和zopiclone之间的DDI,需要降低剂量.
- 提供基于体重的特定克洛扎剂量建议,有或没有佐皮克隆.
结论:
- 同时使用佐皮克隆和克洛沙平需要减少克洛沙平的剂量.
- 对于精神分裂症患者,建议对克洛扎的剂量进行个性化调整,特别是在同时服用佐皮克隆时.
相关概念视频
Nonlinear Pharmacokinetics: Dependence of Elimination Half-Life and Dose Clearance
634
The elimination half-life and drug clearance of drugs following nonlinear kinetics can vary with dosage. The Michaelis-Menten parameters and drug concentration influence these factors. As the dose increases, the elimination half-life tends to lengthen, resulting in a reduction in clearance and a disproportionately larger area under the curve. The total clearance can be derived from the Michaelis-Menten equation for drugs following a one-compartment model.
A study on guinea pigs examined the...
A study on guinea pigs examined the...
634
Analysis of Population Pharmacokinetic Data
677
Analysis of population pharmacokinetic data involves studying the behavior of drugs within diverse populations to understand their pharmacokinetic parameters. Traditional pharmacokinetic methods typically involve collecting samples from a few individuals and estimating these parameters. While these methods are commonly used, they have limitations in capturing the variability in drug response among individuals or heterogeneous populations. Population pharmacokinetics is employed to address these...
677
Pharmacokinetics: Drug–Drug Interactions
355
Drug interactions occur when the pharmacological effect of one drug is altered by another substance, either enhancing or diminishing its activity. The drug whose activity is altered is known as the object drug, and the substance causing the alteration is called the agent drug or the precipitant. The net effects of these interactions are mostly undesirable, leading to decreased effectiveness or increased adverse effects. In rare cases, interactions can be beneficial, such as the enhanced...
355
Physiological Pharmacokinetic Models: Assumption with Protein Binding
211
Physiological models with protein binding in pharmacokinetics offer a sophisticated approach to understanding drug disposition. These models consider drug-protein interactions, enabling them to effectively predict drug concentrations in different organs and tissues. This precision aids in accurate drug dosing, providing a significant advantage over conventional models. A key process within these models is equilibration, which ensures that drug concentrations achieve a steady state within the...
211
Pharmacokinetic Models: Overview
1.9K
Pharmacokinetic models utilize mathematical analysis to achieve a detailed quantitative understanding of a drug's life cycle within the body. They are instrumental in simulating a drug's pharmacokinetic parameters, predicting drug concentrations over time, optimizing dosage regimens, linking concentrations with pharmacologic activity, and estimating potential toxicity.
There are three primary types of models: empirical, compartment, and physiological. Empirical models, with minimal...
There are three primary types of models: empirical, compartment, and physiological. Empirical models, with minimal...
1.9K
Chronopharmacokinetics: Circadian Rhythms and Influence on Drug Response
350
Circadian rhythms are cyclic changes that are crucial in plasma drug concentrations. Various standard circadian parameters, including core body temperature, heart rate, and other cardiovascular factors, directly impact disease states and the therapeutic response to drug therapy.
The time of drug administration is an important factor to consider, as it can influence the toxic dose of a drug. For example, a study conducted by Prins et al. in 1997 examined the effects of the timing of...
The time of drug administration is an important factor to consider, as it can influence the toxic dose of a drug. For example, a study conducted by Prins et al. in 1997 examined the effects of the timing of...
350


